Name and surname:
|
doc. MUDr. Martin Čaprnda, PhD.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
Assistant Professor | Comenius University in Bratislava, Faculty of Medicine | 2005 - 2021 |
Associated Professor | Comenius University in Bratislava, Faculty of Medicine | 2021 - now |
Physician | University Hospital Bratislava, 2nd Department of Internal Medicine | 2001 - 2016 |
Physician | University Hospital Bratislava, 1st Department of Internal Medicine | 2016 - now |
IV.a - Activity description, course name, other | IV.b - Name of the institution | IV.c - Year |
---|---|---|
Specialization in Internal Medicine 1st Degree | Slovak Medical University, Bratislava, Slovakia | 2004 |
Specialization in Internal Medicine | Institute for Postgradual Education in Medicine, Prague, Czech Republic | 2010 |
Specialization in Healthcare Management | Comenius University in Bratislava, Faculty of Medicine | 2016 |
V.1.a - Name of the profile course | V.1.b - Study programme | V.1.c - Degree | V.1.d - Field of study |
---|---|---|---|
Internal Propedeutics | General Medicine | I. + II. | General Medicine |
Internal Medicine | General Medicine | I. + II. | General Medicine |
Caprnda M, Zulli A, Shiwani HA, et al. The therapeutic effect of B-type natriuretic peptides in acute decompensated heart failure. Clin Exp Pharmacol Physiol. 2020 Jul;47(7):1120-1133. IF (JCR) 2020=2,557
Liskova A, Samec M, Koklesova L, Caprnda M, et al. Flavonoids against the SARS-CoV-2 induced inflammatory storm. Biomed Pharmacother. 2021 Jun;138:111430. IF (JCR) 2020=6,529
Abotaleb M, Kubatka P, Caprnda M, et al. Chemotherapeutic agents for the treatment of metastatic breast cancer: An update. Biomed Pharmacother. 2018 May;101:458-477. IF (JCR) 2018=3,743
Lind M, Hayes A, Caprnda M, et al. Inducible nitric oxide synthase: Good or bad? Biomed Pharmacother. 2017 Sep;93:370-375. IF (JCR) 2017=3,457
Caprnda M, Kubatka P, Gazdikova K, et al. Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders. Biomed Pharmacother. 2017 Jul;91:60-69. IF (JCR) 2017=3,457
Kusenda P, Caprnda M, Gabrielova Z, Kukova N, Pavlovic S, Stefanickova J. Understanding Loss to Follow-Up in AMD Patients Receiving VEGF Inhibitor Therapy: Associated Factors and Underlying Reasons. Diagnostics (Basel). 2024;14(4):400. IF (JCR) 2022=3.6
Mihalov P, Hodosy J, Koščálová A, Čaprnda M, Kachlíková M, Jurenka J, Bendžala M, Sabaka P. Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit. Can J Infect Dis Med Microbiol. 2023 Sep 14;2023:4951273. IF (JCR) 2022=2.8
Russo E, Caprnda M, Kruzliak P, Conaldi PG, Borlongan CV, La Rocca G. Umbilical Cord Mesenchymal Stromal Cells for Cartilage Regeneration Applications. Stem Cells Int. 2022 Jan 6;2022:2454168. IF (JCR) 2022=4.3
Jurenka J, Nagyová A, Dababseh M, Mihalov P, Stankovič I, Boža V, Kravec M, Palkovič M, Čaprnda M, Sabaka P. Anti-SARS-CoV-2 Antibody Status at the Time of Hospital Admission and the Prognosis of Patients with COVID-19: A Prospective Observational Study. Infect Dis Rep. 2022 Dec 11;14(6):1004-1016. IF (JCR) 2022=3.2
Mazurakova A, Koklesova L, Samec M, Kudela E, Sivakova J, Pribulova T, Pec MJ, Pec M, Kello M, Büsselberg D, Golubnitschaja O, Gaspar L, Caprnda M, Adamek M, Prosecky R, Eminova E, Baranenko D, Kruzliak P, Kubatka P, Biringer K. Flavonoids exert potential in the management of hypertensive disorders in pregnancy. Pregnancy Hypertens. 2022 Aug;29:72-85. IF (JCR) 2022=2.2
Lind M, Hayes A, Caprnda M, et al. Inducible nitric oxide synthase: Good or bad? Biomed Pharmacother. 2017 Sep;93:370-375. CITATION: afonte RD, Wang L, Arbelaez CA, Dennison R, Teng YD. Medical Gas Therapy for Tissue, Organ, and CNS Protection: A Systematic Review of Effects, Mechanisms, and Challenges. Adv Sci (Weinh). 2022 Mar 4:e2104136.
Gasparova I, Kubatka P, Opatrilova R, Caprnda M, et al. Perspectives and challenges of antioxidant therapy for atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol. 2017 Jan;390(1):1-14. CITATION: Rahm AK, Helmschrott M, Darche FF, et al. Newly acquired complete right bundle branch block early after heart transplantation is associated with lower survival. ESC Heart Fail. 2021 Oct;8(5):3737-3747.
Abotaleb M, Kubatka P, Caprnda M, et al. Chemotherapeutic agents for the treatment of metastatic breast cancer: An update. Biomed Pharmacother. 2018 May;101:458-477. IF (JCR) 2018=3,743. CITATION: Plava J, Burikova M, Cihova M, et al. Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer. J Exp Clin Cancer Res. 2021 Sep 27;40(1):302.
Liskova A, Samec M, Koklesova L, Caprnda M, et al. Flavonoids against the SARS-CoV-2 induced inflammatory storm. Biomed Pharmacother. 2021 Jun;138:111430. IF (JCR) 2020=6,529. CITATION: arghese E, Samuel SM, Liskova A, Kubatka P, Büsselberg D. Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing. PLoS Pathog. 2021 Jun 22;17(6):e1009634.
Gasparova I, Kubatka P, Opatrilova R, Caprnda M, et al. Perspectives and challenges of antioxidant therapy for atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol. 2017 Jan;390(1):1-14. CITATION: Singh JA, Cleveland JD. Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: a propensity-matched analysis of Medicare claims data. Eur Heart J. 2019 Sep 21;40(36):3046-3054.
2016-2019 Vedecká grantová agentúra Ministerstva školstva, vedy, výskumu a športu SR - VEGA 2/0161/16 - Vplyv chronického zápalu na kardiometabolické parametre
VII.a - Activity, position | VII.b - Name of the institution, board | VII.c - Duration |
---|---|---|
Board Member of Slovak Society of Atherosclerosis | Slovak Society of Atherosclerosis | 2011 - now |